New York University Intelligence

Over 1.1 million Americans received off-label GLP-1 prescriptions, study finds

A study finds over 1.1 million Americans without obesity or diabetes received off-label GLP-1 prescriptions like Ozempic and Wegovy. What this means for healthcare and startups.